Philip L. Saxton

In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent.

Junke Liu, Murray J. Towle, Hongsheng Cheng et al. · PubMed · 2007 · 78 citations

Medicine, Oncology, Pharmacology +16

A high-performance liquid chromatography–tandem mass spectrometry method for the clinical combination study of carboplatin and anti-tumor agent eribulin mesylate (E7389) in human plasma

C. Desjardins, Philip L. Saxton, S LU et al. · Journal of Chromatography B · 2008 · 27 citations

Medicine, Biochemistry, Oncology +12

Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model

Sridhar Narayan, Eric M. Carlson, Hongsheng Cheng et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 24 citations

Medicine, Oncology, Pharmacology +17

Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo

Sridhar Narayan, Eric M. Carlson, Hongsheng Cheng et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 19 citations

Medicine, Oncology, Pharmacology +6

A pharmacokinetic evaluation of HIV protease inhibitors, cyclic ureas, in rats and dogs

Y. Nancy Wong, Deborah L. Burcham, Philip L. Saxton et al. · Biopharmaceutics & Drug Disposition · 1994 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +16